BioLife Solutions to Report Third Quarter 2024 Financial Results and Business Update on November 12, 2024

BLFS 10.31.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-11-12
Name of Upcoming Event:BioLife Solutions Earnings Conference Call
Full Press ReleaseSEC FilingsOur BLFS Tweets

About Gravity Analytica

Recent News

  • 01.22.2025 - Navigating Current Standards and Compliance for Cell and Gene Therapy (CGT) Storage Containers
  • 01.13.2025 - BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2024 Unaudited Revenue from Continuing Operations
  • 12.16.2024 - BioLife Solutions Appoints Tony J. Hunt to its Board of Directors

Recent Filings

  • 01.13.2025 - 8-K Current report
  • 01.13.2025 - EX-99.1 EX-99.1
  • 01.10.2025 - 3 Initial statement of beneficial ownership of securities
Investor Contact

Media & Investor Relations:
Troy Wichterman
Chief Financial Officer
(425) 402 - 1400
twichterman@biolifesolutions.com

Transfer Agent

Broadridge Corporate Issuer Solutions, Inc.
P.O. Box 1342
Brentwood, New York 11717
USA
(877) 830 - 4936
shareholder@broadridge.com

Investor Alerts

Register hereto receive email notifications with updates about our press releases, stock price, SEC filings and more.

Press Releases

BioLife Solutions to Report Third Quarter 2024 Financial Results and Business Update on November 12, 2024

BOTHELL, Wash.,Oct. 31, 2024/PRNewswire/ --BioLife Solutions, Inc. (NASDAQ:BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's third quarter 2024 financial results will be released after market close onTuesday, November 12, 2024. The Company will host a conference call and live webcast at4:30pm ET(1:30pm PT) that day. Management will provide an overview of the Company's financial results and give a general business update.

BioLife Solutions New Logo 2021 (PRNewsfoto/BioLife Solutions, Inc.)

To access the webcast, log onto the Investor Relations page of the BioLife Solutions website athttps://www.biolifesolutions.com/earnings.In addition, the conference call will be accessible by dialing toll-free 1-833-630-0431 or 1-412-317-1808 for international callers. A webcast replay will be available approximately two hours after the call and will be archived onhttps://investors.biolifesolutions.comfor 90 days.

About BioLife Solutions
BioLife Solutions is a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visitwww.biolifesolutions.comor follow BioLife onLinkedInandX.

Media & Investor Relations

At the Company
Troy Wichterman
Chief Financial Officer
(425) 402-1400
twichterman@biolifesolutions.com

Investors
LHA Investor Relations
Jody Cain
(310) 691-7100
jcain@lhai.com

SOURCE BioLife Solutions, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com